Literature DB >> 10713895

Late whiplash syndrome: a clinical and magnetic resonance imaging study.

U Bonuccelli1, N Pavese, C Lucetti, M R Renna, G Gambaccini, S Bernardini, R Canapicchi, L Carrozzi, L Murri.   

Abstract

Cervical hyperextension injuries are common and are associated with significant morbidity. Clinically two syndromes are described: "acute" whiplash syndrome and "late" whiplash syndrome (in which the patients are still symptomatic after six months despite normal physical and radiological examination). In order to clarify the pathology of the persistent pain in late whiplash syndrome we performed a cervical spine magnetic resonance imaging (MRI) in 33 consecutive patients suffering from this condition. Twenty-six patients (78.8%) showed MRI abnormalities, the most common MRI finding (57.6%) was pre-existent spondylosis. Indeed, the group of patients with spondylosis and other MRI changes had higher clinical scores than those without MRI abnormalities as measured by a three-point grading system based upon the symptoms and signs shown. Several MRI changes, most of them already demonstrable by standard X-ray were seen among 33 patients suffering from late whiplash syndrome. Although no one of these findings appears to be specific and certainly related to the previous neck injury, they could represent a risk factor for a longer pain duration.

Entities:  

Mesh:

Year:  1999        PMID: 10713895

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  2 in total

Review 1.  Whiplash associated disorders: a review of the literature to guide patient information and advice.

Authors:  T McClune; A K Burton; G Waddell
Journal:  Emerg Med J       Date:  2002-11       Impact factor: 2.740

2.  Are early MRI findings correlated with long-lasting symptoms following whiplash injury? A prospective trial with 1-year follow-up.

Authors:  Alice Kongsted; Joan S Sorensen; Hans Andersen; Bjarne Keseler; Troels S Jensen; Tom Bendix
Journal:  Eur Spine J       Date:  2008-05-30       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.